Patents by Inventor Francis E. Nano

Francis E. Nano has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • VACCINES COMPRISING HEAT-SENSITIVE TRANSGENES
    Publication number: 20170136111
    Abstract: The present disclosure provides temperature sensitive essential nucleic acid molecules from a psychrophilic bacterium, proteins encoded by the nucleic acid molecules, as well as recombinant cells into which have been introduced such nucleic acid molecules. The disclosed recombinant cells containing one or more essential nucleic acid molecules from a psychrophilic bacterium are thereby made temperature sensitive, and can be administered to a mammal to induce an immune response in the mammal.
    Type: Application
    Filed: January 24, 2017
    Publication date: May 18, 2017
    Applicant: UVic Industry Partnerships Inc.
    Inventor: Francis E. Nano
  • Vaccines comprising heat-sensitive transgenes
    Patent number: 9580478
    Abstract: The present disclosure provides temperature sensitive essential nucleic acid molecules from a psychrophilic bacterium, proteins encoded by the nucleic acid molecules, as well as recombinant cells into which have been introduced such nucleic acid molecules. The disclosed recombinant cells containing one or more essential nucleic acid molecules from a psychrophilic bacterium are thereby made temperature sensitive, and can be administered to a mammal to induce an immune response in the mammal.
    Type: Grant
    Filed: March 12, 2013
    Date of Patent: February 28, 2017
    Assignee: UVIC INDUSTRY PARTNERSHIPS INC.
    Inventor: Francis E. Nano
  • Vaccines comprising heat-sensitive transgenes
    Patent number: 8778683
    Abstract: The present disclosure provides temperature sensitive essential nucleic acid molecules from a psychrophilic bacterium, proteins encoded by the nucleic acid molecules, as well as recombinant cells into which have been introduced such nucleic acid molecules. The disclosed recombinant cells containing one or more essential nucleic acid molecules from a psychrophilic bacterium are thereby made temperature sensitive, and can be administered to a mammal to induce an immune response in the mammal.
    Type: Grant
    Filed: October 7, 2010
    Date of Patent: July 15, 2014
    Assignee: UVic Industry Partnerships Inc.
    Inventor: Francis E. Nano
  • VACCINES COMPRISING HEAT-SENSITIVE TRANSGENES
    Publication number: 20120189661
    Abstract: The present disclosure provides temperature sensitive essential nucleic acid molecules from a psychrophilic bacterium, proteins encoded by the nucleic acid molecules, as well as recombinant cells into which have been introduced such nucleic acid molecules. The disclosed recombinant cells containing one or more essential nucleic acid molecules from a psychrophilic bacterium are thereby made temperature sensitive, and can be administered to a mammal to induce an immune response in the mammal.
    Type: Application
    Filed: October 7, 2010
    Publication date: July 26, 2012
    Inventor: Francis E. Nano
  • Mycobacterium tuberculosis DNA sequences encoding immunostimulatory peptides and methods for using same
    Patent number: 6572865
    Abstract: Nucleotide sequences isolated from Mycobacterium tuberculosis are disclosed. These sequences encode immunostimulatory peptides. Also disclosed are vaccine preparations formulated using these peptides.
    Type: Grant
    Filed: January 3, 2000
    Date of Patent: June 3, 2003
    Assignee: University of Victoria Innovation and Development Corporation
    Inventor: Francis E. Nano
  • Mycobacterium tuberculosis DNA sequences encoding immunostimulatory peptides and methods for using same
    Publication number: 20030049269
    Abstract: Nucleotide sequences isolated from Mycobacterium tuberculosis are disclosed. These sequences encode immunostimulatory peptides. Also disclosed are vaccine preparations formulated using these peptides.
    Type: Application
    Filed: November 28, 2001
    Publication date: March 13, 2003
    Applicant: University of Victoria Innovation and Development Corporation
    Inventor: Francis E. Nano
  • Mycobacterium tuberculosis DNA sequences encoding immunostimulatory peptides and methods for using same
    Publication number: 20030049263
    Abstract: Nucleotide sequences isolated from Mycobacterium tuberculosis are disclosed. These sequences encode immunostimulatory peptides. Also disclosed are vaccine preparations formulated using these peptides.
    Type: Application
    Filed: November 28, 2001
    Publication date: March 13, 2003
    Applicant: University of Victoria Innovation and Development Corporation
    Inventor: Francis E. Nano
  • Mycobacterium tuberculosis DNA sequences encoding immunostimulatory peptides and methods for using same
    Publication number: 20020172684
    Abstract: Nucleotide sequences isolated from Mycobacterium tuberculosis are disclosed. These sequences encode immunostimulatory peptides. Also disclosed are vaccine preparations formulated using these peptides.
    Type: Application
    Filed: November 28, 2001
    Publication date: November 21, 2002
    Applicant: University of Victoria Innovation and Development Corporation
    Inventor: Francis E. Nano
  • Mycobacterium tuberculosis DNA sequences encoding immunostimulatory peptides
    Patent number: 6228371
    Abstract: Nucleotide sequences isolated from Mycobacterium tuberculosis are disclosed. These sequences are shown to encode immunostimulatory peptides. The invention encompasses, among other things, vaccine preparations formulated using these peptides.
    Type: Grant
    Filed: December 15, 1997
    Date of Patent: May 8, 2001
    Assignee: University of Victoria Innovation and Development Corp.
    Inventor: Francis E. Nano
  • Recombinant clones of Chlamydia trachomatis lipopolysaccharide
    Patent number: 5075228
    Abstract: Disclosed is a clone and the process for cloning genes encoding the genus-specific lipopolysaccharide antigen of chlamydia. The clone is a hybrid lipopolysaccharide molecule composed of both chlamydia and E. coli components.
    Type: Grant
    Filed: September 27, 1990
    Date of Patent: December 24, 1991
    Assignee: United States of America
    Inventors: Francis E. Nano, Harlan D. Caldwell